Technologies

Apple to Halt Sales of Its Newest Apple Watches. Here’s What to Know

Apple is pausing sales of the Series 9 and Ultra 2 in the US as part of an ongoing legal dispute. The Apple Watch SE is unaffected.

Apple will pause sales of its Apple Watch Series 9 and Ultra 2 smartwatches in the US this month as the result of an ongoing legal battle with health tech company Masimo.

The US International Trade Commission, the federal agency that handles trade-related mandates, previously issued an order that would prohibit Apple from importing the Series 9 and Ultra 2. The decision came after a US judge ruled in January that Apple infringed on Masimo patents related to the technology used in Apple’s blood oxygen sensing system. The order is currently under presidential review, but Apple is preemptively pausing sales in case the decision is upheld, the company said. The move was first reported by 9to5Mac on Monday, and Apple has since confirmed its decision to CNET.

The Apple Watch is one of Apple’s most important products, helping push the company’s wearables, home and accessories business to be its second-largest product category behind the iPhone. Apple has previously said the size of its wearables unit alone equals that of a Fortune 150 company.

Apple will stop selling the Series 9 and Ultra 2 through its website on Dec. 21, while Apple stores will stop selling the watches on Dec. 24.

«Apple’s teams work tirelessly to create products and services that empower users with industry-leading health, wellness and safety features,» the company said in a statement to CNET. «Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that [the] Apple Watch is available to customers.»

The company added that it will «continue to take all measures to return [the] Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the US as soon as possible,» if the order stands.

Apple’s pause of Apple Watch sales comes during the critical holiday shopping season. Smartwatches were among the top products sold during the Black Friday period, according to holiday shopping data from Adobe.

When the judge’s ruling was made in January, Masimo CEO Joe Kiani said the decision «should help restore fairness in the market.»

Here’s what to know about Apple’s pause in sales of the Series 9 and Ultra 2. This story will be updated as we receive more information.

When will Apple stop selling the Apple Watch Series 9 and Ultra 2?

Apple will stop selling the Series 9 and Ultra 2 online at noon PT (3 p.m. ET) on Dec. 21, according to Apple. The company said the last day for the pickup and delivery of online orders, as well as in-store sales, will be end of day Dec. 24.

Can I still buy the Apple Watch Series 9 and Ultra 2 from other retailers?

The order affects sales of the Apple Watch Series 9 and Ultra 2 through Apple specifically. But 9to5Mac points out that the order prohibits Apple from importing these watches and selling them to resellers, which means they may only be available through other retailers for a limited time.

However, the order only applies to sales in the US, meaning you should still be able to purchase the Series 9 and Ultra 2 abroad.

Best Buy told CNET it will continue selling the Apple Watch Series 9 and Ultra 2 in the US after Dec. 25 even if the order stands.

Which Apple Watch models are affected?

The Apple Watch Series 9 and Apple Watch Ultra 2 are the only models affected. Since the legal dispute involves the blood oxygen sensing tech used in the Apple Watch, the Apple Watch SE will continue to be sold as usual. The Apple Watch SE is the lower-end model in Apple’s lineup, meaning it’s missing some health tracking features like blood oxygen sensing and the ability to take an ECG.

Current Apple Watches with blood oxygen monitoring, which includes any non-SE models starting with the Series 6, also won’t be affected.

What is Masimo and why is Apple pausing sales?

Masimo is a medical technology company that creates professional and consumer health products, including a smartwatch called the Masimo W1. The sales pause is the latest development in an ongoing legal dispute between Apple and Masimo, in which the latter accused Apple of infringing on its pulse oximeter patents.

What happens next?

The presidential review period ends on Dec. 25, so we’re expecting to learn more about whether the import ban will stand after that deadline. Apple also plans to appeal the ITC’s decision to the federal circuit, the company said.

It’s rare for an order like this to be vetoed, said Rochelle Dreyfuss, professor of law emerita at the New York University School of Law. But it’s happened before, specifically in 2013 when the Obama administration vetoed a ban that would have blocked the sale of certain older iPhone and iPad models in the US after the ITC found that Apple had infringed on Samsung patents.

The Apple Watch is a health product, which could work in Apple’s favor when it comes to the presidential review process, Dreyfuss said. But there are also plenty of other products that offer blood oxygen monitoring, which is the specific function at the heart of the legal dispute.

«Are there other industries that provide exactly the same service? So can Americans actually get that product?» she said. «That’s something that the industry has already decided against Apple. … So this would be the president sort of interfering with that decision,» she added, referring to if the Biden administration were to veto the ITC decision.

If I can’t buy an Apple Watch Series 9 or Ultra 2, what are my alternatives?

It’s worth waiting to see what happens after the presidential review process before making any decisions. Those with an iPhone who just want a smartwatch for tracking activity, workouts and sleep should consider the $249 Apple Watch SE. While that watch lacks ECG and blood oxygen monitoring, it can still provide notifications for high and low heart rates and irregular heart rhythms.

The Apple Watch SE is the best choice for those who are most comfortable in Apple’s ecosystem, but there are also other options that work across iPhone and Android, like the Fitbit Versa 4 and Garmin Venu 3.

Those who are looking to monitor blood oxygen levels from home specifically should consider buying a standalone pulse oximeter, said Jennifer Schrack, professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health.

«Consumer wearables are a great supplemental way for people stay informed about their health, but they are subject to error,» Schrack said over email. «It is important to remember that they are measuring blood oxygen using PPG sensors, which can be affected by things like skin tone.»

But again, if your heart is set on the Series 9 or Ultra 2, and you aren’t in a position to buy one right now, it’s worth waiting to see whether the ITC’s order stands before making a decision.

Technologies

Stroke Risk Could Be Flagged Early Using Apple Watch Technology, Studies Show

The latest research shows that wearables could soon be a vital part of tracking your heart health.

For millions at risk of stroke, a simple tap on the wrist could one day save lives. New studies from the Amsterdam University Medical Center and St. Bartholomew’s Hospital in London showed that wearables, such as the Apple Watch, can improve the detection of atrial fibrillation compared to standard care. Atrial fibrillation, often referred to as A-fib, is a heart arrhythmia, which means an irregular or abnormal heartbeat. The condition can cause blood clots and is one of the leading causes of a stroke.

The Amsterdam study enrolled 437 patients aged 65 or older with elevated stroke risk and required 219 of them to wear an Apple Watch to track their heart rate for 12 hours a day for 6 months. The remaining 218 patients didn’t wear a watch and relied on standard care.

The experiment detected heart arrhythmias four times more frequently in patients wearing an Apple Watch versus those who didn’t. Specific versions of the Apple Watch use photoplethysmography, a heart rate-detecting LED light sensor, and have a built-in single-lead electrocardiogram sensor to read your heart rate.

Don’t miss any of our unbiased tech content and lab-based reviews. Add CNET as a preferred Google source.

Wearables that track heart rate and other health markers aren’t new, and previous studies have shown promise in detecting A-fib. Although wearables are known to track this type of data, no prior research has examined how well they detect potential health risks for A-fib.

«We saw that after six months we diagnosed and treated 21 patients in the group wearing the smartwatch, of whom 57% were asymptomatic,» said Michiel Winter, a cardiologist at Amsterdam UMC, in a statement. «This was against just five diagnoses in the group receiving standard care, all of whom experienced symptoms.»

The second clinical study, conducted by St. Bartholomew’s Hospital, showed that the Apple Watch could also be beneficial for detecting A-fib symptoms earlier and for monitoring patients after a standard treatment, such as a catheter ablation. The hospital found that patients could record clinical-grade ECGs on their Apple Watches at home when experiencing symptoms. Similar to the first study, the hospital found that patients using an Apple Watch detected A-fib earlier and more frequently than those receiving standard care. Catching symptoms earlier also reduces anxiousness and the likelihood that a patient will need to be hospitalized.

The findings from these studies show that wearables such as the Apple Watch could be used for long-term heart screening to detect heart health abnormalities and improve patient care for those in treatment. And it can help diagnose those who don’t know they have the condition.

«Using smartwatches with PPG and ECG functions aids doctors in diagnosing individuals unaware of their arrhythmia, thereby expediting the diagnostic process,» said Winter.

Technologies

Today’s NYT Mini Crossword Answers for Thursday, Jan. 29

Here are the answers for The New York Times Mini Crossword for Jan. 29.

Looking for the most recent Mini Crossword answer? Click here for today’s Mini Crossword hints, as well as our daily answers and hints for The New York Times Wordle, Strands, Connections and Connections: Sports Edition puzzles.

Need some help with today’s Mini Crossword? It’s one of those neat, solid grids with no empty squares. Read on for all the answers. And if you could use some hints and guidance for daily solving, check out our Mini Crossword tips.

If you’re looking for today’s Wordle, Connections, Connections: Sports Edition and Strands answers, you can visit CNET’s NYT puzzle hints page.

Read more: Tips and Tricks for Solving The New York Times Mini Crossword

Let’s get to those Mini Crossword clues and answers.

Mini across clues and answers

1A clue: Employees, collectively
Answer: STAFF

6A clue: The «L» of TTYL
Answer: LATER

7A clue: Slowly lessen, as political support
Answer: ERODE

8A clue: Dunkin’ offering
Answer: DONUT

9A clue: Tricky things to navigate with a stroller
Answer: STEPS

Mini down clues and answers

1D clue: Toys that go on the decline in winter?
Answer: SLEDS

2D clue: Set of fortunetelling cards
Answer: TAROT

3D clue: Make amends
Answer: ATONE

4D clue: Out of patience
Answer: FEDUP

5D clue: Guitar bars
Answer: FRETS

Don’t miss any of our unbiased tech content and lab-based reviews. Add CNET as a preferred Google source.

Technologies

Mobile Internet Without Borders: How Verum E-SIM Is Changing the Game for Travelers and Beyond

In an era when flights take just a few hours, but data boundaries remain very real, a solution has emerged that significantly simplifies life for frequent international travelers. The Verum E-SIM app offers a next-generation virtual SIM card — no plastic, no waiting for delivery, and no traditional roaming charges.

While eSIM technology itself is no longer new, Verum takes it further: the internet works in over 150 countries worldwide under clear, uniform conditions. Connection happens through the app in just a couple of minutes — choose a package (or even a global one), pay, and activate. No need to buy local SIM cards at the airport, hunt for carrier shops, or struggle with explanations in a foreign language.

One of the biggest advantages is the complete absence of hidden fees or billing surprises. Plans are fully transparent: you immediately see how many gigabytes you get and for how long. Speed and reliability are provided by partner operators in each specific country — this isn’t a single “averaged” provider for the entire world.

Another key point for many users is that no VPN is required. As long as your device is using Verum E-SIM traffic, all familiar services and websites open directly, without extra layers or speed loss.

For those traveling with a group or family, portable Wi-Fi routers with Verum eSIM support have become a great option. One profile — and the internet is shared simultaneously across multiple smartphones, tablets, and laptops. It’s convenient on the road, in a hotel, or even in a café where the local Wi-Fi is unreliable.

Payment flexibility is also a plus: the service supports regular bank cards, cryptocurrencies, and various alternative methods — so you can choose whatever feels most convenient and cost-effective for you.

In the end, Verum E-SIM is more than just another data app. It’s a way to make mobile internet as natural and hassle-free abroad as it is at home. The difference becomes especially clear when you compare a roaming bill from one of the major operators with your Verum expenses after two or three trips.

The technology is still gaining popularity, but many travelers are already saying: “For the first time in ages, internet abroad stopped being a source of stress.” Solutions like this are shaping the future of mobile connectivity — without extra cables, borders, or unpleasant surprises.

If you travel often or simply value stable internet without unnecessary hassle — it’s worth giving it a try at least once.

https://esim.verum.im

https://esimglobal.world